Caspian Capital’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-299,542
Closed -$5.13M 8
2018
Q4
$5.13M Sell
299,542
-225,458
-43% -$5.46M 9.3% 3
2018
Q3
$14.9M Buy
525,000
+100,000
+24% +$3.3M 19.34% 2
2018
Q2
$14.3M Buy
425,000
+30,900
+8% +$961K 26.21% 2
2018
Q1
$9.56M Sell
394,100
-530,900
-57% -$10.6M 21.35% 2
2017
Q4
$14M Hold
925,000
22.1% 2
2017
Q3
$15.2M Buy
925,000
+400,000
+76% +$6.78M 11.05% 4
2017
Q2
$10.2M Buy
+525,000
New +$9.16M 1.19% 6

Other funds holding THC

Caspian Capital's THC Position: Q1 2019 in Review

Caspian Capital sold out of Tenet Healthcare (THC) in Q1 2019, closing a stake of 299,542 shares — an estimated $5.13M sold.

Caspian Capital first reported a position in THC in Q2 2017 and held it in 7 quarters. The position peaked at $15.2M in Q3 2017. 260 funds tracked by Wall St. Rank hold THC as of Q1 2019.

  • Caspian Capital reported no remaining Tenet Healthcare position as of Q1 2019 after selling out during the quarter.
  • Caspian Capital sold 299,542 Tenet Healthcare shares in Q1 2019, an estimated $5.13M.
  • Caspian Capital first reported a position in Tenet Healthcare in Q2 2017 and held it in 7 quarters.
  • Caspian Capital's Tenet Healthcare position peaked at $15.2M in Q3 2017.
  • 260 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2019.

Based on Caspian Capital's 13F filing for Q1 2019, filed 15 May 2019.